Indiva Announces Filing of Amended and Restated Offering Document and Concurrent Private Placement of up to $4.3 Million Date Tuesday, February 27, 2024 - 10:00 PM Description Business Wire (English); 02/28/2024(AN bizwire.20240228087111)Business Source Corporate Plus
An appraisal of traditional knowledge of plant poisoning of livestock and its validation through acute toxicity assay in rats. Date Tuesday, February 27, 2024 - 10:00 PM Description Frontiers in Pharmacology; 02/28/2024(AN 175745801); ISSN: 16639812Complementary Index
Greenway Announces Third Quarter Financial Statements Date Tuesday, February 27, 2024 - 10:00 PM Description PR Newswire US; 02/28/2024(AN 202402281715PR.NEWS.USPR.TO48149)Business Source Corporate Plus
The deluded fantasy world of Beau Lamarre-Condon Date Tuesday, February 27, 2024 - 10:00 PM Description Sydney Morning Herald, The; 02/28/2024(AN DOC7UBM0J3YLECTYD8MKE9); ISSN: 03126315Business Source Corporate Plus
Lawmakers weigh whether ‘iGaming’ should be gambling’s next move in Maryland Date Tuesday, February 27, 2024 - 10:00 PM Description Baltimore Sun, The (MD); 02/28/2024(AN 2W62178310302)Business Source Corporate Plus
Going 'California Sober' May Be Bad for Your Heart. Date Tuesday, February 27, 2024 - 10:00 PM Description Bloomberg Opinion; 02/28/2024(AN 175720582)Business Source Corporate Plus
Tools to implement measurement-based care (MBC) in the treatment of opioid use disorder (OUD): toward a consensus. Date Tuesday, February 27, 2024 - 10:00 PM Description Addiction Science & Clinical Practice; 02/28/2024(AN 175753641); ISSN: 19400632Complementary Index
Organigram Applauds the Standing Committee on Finance’s Recommendation on Excise Duty Date Tuesday, February 27, 2024 - 10:00 PM Description Business Wire (English); 02/28/2024(AN bizwire.20240228644763)Business Source Corporate Plus
Q4 2023 Turning Point Brands Inc Earnings Call - Final Date Tuesday, February 27, 2024 - 10:00 PM Description Fair Disclosure Wire (Quarterly Earnings Reports); 02/28/2024(AN 32U0052844666FDW)Business Source Corporate Plus
Lavie Bio Successfully Secures Second Half Advance Payment of $2.5M after Meeting Corteva's Licensing Agreement Requirements Date Tuesday, February 27, 2024 - 10:00 PM Description PR Newswire US; 02/28/2024(AN 202402280700PR.NEWS.USPR.LN47885)Business Source Corporate Plus